Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem

Ipilimumab plus nivolumab prolongs survival in melanoma with brain metastases
Treatment with ipilimumab plus nivolumab improves long-term survival in melanoma patients with asymptomatic brain metastases, according to the results of the NIBIT-M2 trial presented at AACR 2026.
Ipilimumab plus nivolumab prolongs survival in melanoma with brain metastases
05 May 2026
Switch to ANV/3TC/TDF keeps viral suppression, lowers LDL-C levels in PLWH
People living with HIV-1 (PLWH) who discontinued traditional non-nucleoside reverse transcriptase inhibitor (NNRTI)- and boosted integrase strand transfer inhibitor (INSTI)-based regimens have maintained viral suppression following their switch to the next-generation NNRTI ainuovirine coformulated with lamivudine and tenofovir DF (ANV/3TC/TDF), as shown by the 144-week open-label results from the SPRINT* post-study presented at ESCMID Global 2026.
Switch to ANV/3TC/TDF keeps viral suppression, lowers LDL-C levels in PLWH
04 May 2026
Baloxavir or oseltamivir – which is more cost-effective for outpatient treatment of influenza in HK?
A payer-perspective study from the University of Hong Kong (HKU) indicates that single-dose baloxavir is a more cost-effective outpatient treatment option for seasonal influenza than oseltamivir, despite baloxavir’s higher acquisition cost.






